SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77502.12
579.48 (0.75%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
91	Aarti Drugs Ltd.	Q V+ PT	3,502 Small Cap	383.75 (2.27%)	17.97	2.26	5.74	4.42	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
92	Alkem Laboratories Ltd.	Q V+ PT	65,712 Mid Cap	5,495.95 (-1.22%)	30.07	4.69	5.71	10.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
93	Viyash Scientific Ltd.	Q V PT	12,772 Small Cap	292.35 (1.48%)	72.04	4.39	5.64	-18.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
94	Granules India Ltd.	Q V+ PT	20,482 Small Cap	826.55 (1.84%)	51.12	4.66	5.58	-0.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
95	Glaxosmithkline Pharmaceuticals Ltd.	Q V PT	40,928 Mid Cap	2,415.95 (-1.93%)	39.51	17.93	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
96	Strides Pharma Science Ltd.	Q V+ PT	10,380 Small Cap	1,126.10 (2.76%)	56.52	3.16	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
97	Glenmark Pharmaceuticals Ltd.	Q V+ PT	61,943 Mid Cap	2,195 (1.73%)	45.48	5.89	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
98	Procter & Gamble Health Ltd.	Q V+ PT	10,725 Small Cap	6,461.25 (1.86%)	32.81	20.45	4.31	11.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
99	Hikal Ltd.	Q V+ PT	2,751 Small Cap	223.15 (2.03%)	N/A	2.3	4.29	-1.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
100	Biocon Ltd.	Q V PT	68,268 Mid Cap	418.90 (0.17%)	1835.16	2.52	2.44	-9.71	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
101	Pfizer Ltd.	Q V PT	20,301 Small Cap	4,437.70 (-0.88%)	28.1	4.83	1.18	5.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
102	Wockhardt Ltd.	Q V+ PT	31,660 Small Cap	1,948.40 (-0.66%)	148.64	6.41	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
103	Laxmi Dental Ltd.	Q V PT	1,236 Small Cap	224.85 (0.81%)	75.23	5	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
104	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	4,409 Small Cap	150.20 (2.00%)	32.03	2.45	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
105	Park Medi World Ltd.	Q V+ PT	12,442 Small Cap	288.05 (-1.89%)	339.79	14.47	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
106	Krsnaa Diagnostics Ltd.	Q V PT	1,857 Small Cap	572.55 (3.79%)	18.31	1.89	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
107	Senores Pharmaceuticals Ltd.	Q V+ PT	6,152 Small Cap	1,335.85 (1.50%)	303.81	8.2	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
108	Onesource Specialty Pharma Ltd.	Q V PT	19,345 Small Cap	1,687.40 (2.38%)	912.09	3.25	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
109	Aarti Pharmalabs Ltd.	Q V+ PT	6,336 Small Cap	698.75 (-0.46%)	35.96	3.2	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
110	Piramal Pharma Ltd.	Q V PT	22,393 Small Cap	168.20 (-0.21%)	31.99	2.75	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
111	Nephrocare Health Services Ltd.	Q V+ PT	6,764 Small Cap	674.15 (-0.64%)	N/A	6.97	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
112	Gujarat Kidney And Super Speciality Ltd.	Q V+ PT	1,033 Small Cap	131 (-0.04%)	104.32	4.19	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
113	Blue Jet Healthcare Ltd.	Q V PT	9,855 Small Cap	568.15 (3.49%)	39.77	7.25	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
114	Fabtech Technologies Ltd.	Q V PT	719 Small Cap	161.75 (2.73%)	29.65	1.84	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
115	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	10,664 Small Cap	4,630.20 (0.40%)	41.35	23.6	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
116	Solara Active Pharma Sciences Ltd.	Q V PT	2,759 Small Cap	571.85 (0.72%)	N/A	2.19	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
117	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	7,759 Small Cap	239.10 (0.65%)	5	5.82	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
118	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,25,057 Large Cap	8,697.55 (0.94%)	83.78	12.55	-3.49	29.94	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
119	Aurobindo Pharma Ltd.	Q V+ PT	89,762 Mid Cap	1,560.05 (0.47%)	37.17	3.95	-3.95	-0.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
120	Novartis India Ltd.	Q V+ PT	3,587 Small Cap	1,452.70 (0.39%)	38.49	4.39	-4.06	54.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Suven Life Sciences	298.65	8.92%
Themis Medicare	119.15	7.73%
Dishman Carbogen Amc	188	7%
Shilpa Medicare	600.85	5.26%
GPT Healthcare	156.45	4.40%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
KMC Speciality Hosp.	133.60	-5.01%
Morepen Laboratories	59.71	-4.63%
Fischer Medical	39.08	-4.59%
Shree Ganesh Remed.	642.40	-4.38%
Gufic Biosciences	385.40	-2.24%

News about Top Pharma Companies in India

Jul, 2026

Alkem Laboratories informs about newspaper advertisement

Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI LODR Regulations, Alkem Laboratories has informed that it enclosed a copy of advertisement published in today's newspapers, Business Standard (English) and Mumbai Lakshadeep (Marathi) for information regarding 52nd Annual General Meeting of the Company to be held through video conferencing (VC)/ other audio visual means (OAVM). The same is also available on the website of the Company at www.alkemlabs.com.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

USFDA completes cGMP inspection at OneSource Specialty Pharma’s SPD facility

The inspection has concluded with one observation

Jul, 2026

Fabtech Technologies informs about outcome of postal ballot

Fabtech Technologies has informed that the Company had sought consent from members of the Company on the following resolutions through Postal Ballot notice dated May 25, 2026: Appointment of Rupal Dhiren Haria (DIN: 10624643) as a Non-Executive Independent Director of the Company; and Appointment of Bharti Khanna (DIN: 05147844) as a Non-Executive Independent Director of the Company. Based on the report issued by our Scrutinizer, CS Rachana Shanbhag, Partner of DA Kamat & Co., Company Secretaries, (FCS: 8227/ CP: 9297), the above resolutions have been passed and the same are deemed to have been approved on the last date of e-voting period i.e., Tuesday, June 30, 2026. The voting results in the format prescribed under Regulation 44(3) of SEBI. Listing. Regulations, along with the Scrutinizer's Report on remote e-voting, in respect of above resolutions are attached. The Voting Results along with the Scrutinizer's Report are available on the Company's website www.fabtechnologies.com and also on the website of NSDL at https://www.evoting.nsdl.com/.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Glenmark Pharmaceuticals informs about media release

Glenmark Pharmaceuticals has informed that, Glenmark Specialty S.A, a wholly owned subsidiary of the company (Glenmark) announced the advancement of its multi-country Phase 3 clinical trial for Trastuzumab rezetecan (SHR-A1811), a HER2-targeted antibody drug conjugate (ADC), for patients with platinum-resistant ovarian cancer (PROC). India will serve as the first country in Glenmark’s licensed markets to initiate patient enrollment for the Phase 3 clinical trial, following the approval of Drugs Controller General of India (DCGI). Glenmark also plans to enroll patients in Australia and South Korea, subject to regulatory approvals. The company has attached media release.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

USFDA completes GMP inspection at Glenmark Pharmaceuticals’ Goa facility

At the end of the inspection, the company was issued a Form 483 with six observations

Jul, 2026

Aarti Pharmalabs surges on inaugurating additional manufacturing block at Tarapur Unit 5

The company has successfully obtained all the necessary permissions and approvals to start the facility

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Health X Platform Ltd.	989 Crore
2	Fischer Medical Ventures Ltd.	2,558 Crore
3	3B Blackbio Dx Ltd.	1,037 Crore
4	Max Healthcare Institute Ltd.	1,09,728 Crore
5	Indegene Ltd.	12,397 Crore
6	Acutaas Chemicals Ltd.	30,212 Crore
7	Rubicon Research Ltd.	22,733 Crore
8	Yatharth Hospital & Trauma Care Services Ltd.	8,313 Crore
9	Dr. Agarwals Health Care Ltd.	15,099 Crore
10	Innova Captab Ltd.	5,605 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,722	54,657	35.22	11.45	24.04	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	72.94	18.81	38.40	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	39.56	9.23	26.73	25.35
Lupin Ltd. (M)	Somewhat Good	2,399	1,09,676	20.57	4.89	11.90	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,09,691	21.76	4.22	13.36	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,525	82,399	101
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	37,225	41.28
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	39.25
Aurobindo Pharma Ltd. (M)	Very Good	1,560	89,762	34.75
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	31.18
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	37,225	55.22	9.22	33.44	15.51
Mankind Pharma Ltd. (M)	Very Good	2,487	1,02,729	50.42	6.27	31.67	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,776	39.56	9.23	26.73	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,12,368	26.78	2.98	14.95	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,804	72.94	18.81	38.40	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,09,691	21.76	4.22	13.36	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,872	4,49,048	39.12	5.37	22.41	23.50
Abbott India Ltd. (M)	Very Good	25,722	54,657	35.22	11.45	24.04	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,12,368	26.78	2.98	14.95	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,195	61,943	45.48	5.89	12.07	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Alkem Laboratories informs about newspaper advertisement

USFDA completes cGMP inspection at OneSource Specialty Pharma’s SPD facility

Fabtech Technologies informs about outcome of postal ballot

Glenmark Pharmaceuticals informs about media release

USFDA completes GMP inspection at Glenmark Pharmaceuticals’ Goa facility

Aarti Pharmalabs surges on inaugurating additional manufacturing block at Tarapur Unit 5

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.